Unveiling new perspectives about the onset of neurological and cognitive deficits in cerebral malaria: exploring cellular and neurochemical mechanisms
Frontiers in Cellular and Infection Microbiology · 06.02.2025 · 15
DOI: 10.3389/fcimb.2025.1506282 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 06.02.2025. Verfasst von Renato M S de Lima und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Neuropharmacology, Biological Science Institute, Federal University of Pará, Belém, Brazil. Hauptthemen laut MEDLINE: Malaria, Cerebral, Cognitive Dysfunction, Malaria, Falciparum, Nervous System Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Federal do Pará, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Cerebral malaria is the most severe and lethal complication caused by Plasmodium falciparum infection, leading to critical neurological impairments and long-term cognitive, behavioral, and neurological sequelae in survivors, particularly affecting children under the age of five. Various hypotheses have been proposed to explain the neurological syndrome associated to cerebral malaria condition, including vascular occlusion and sequestration, cytokine storm or inflammatory response, or a combination of these mechanisms and despite extensive research and a growing range of scientific information, the precise pathophysiological mechanism remains poorly understood. In this sense, this review aims to explore the neurological impairment in cerebral malaria and elucidate novel mechanisms to explain the severity of this disease. Recent evidence implicates glutamate and glutamatergic pathways in the onset of cerebral malaria, alongside the impairments in the metabolic activity of other molecules such as dopamine and kynurenic acid. These neurotransmitters pathways may play a crucial role in the pathogenesis of cerebral malaria, potentially interacting with other molecular players. By enhancing our understanding in the pathophysiology of cerebral malaria, this article seeks to explore new hypotheses regarding the involvement of neurotransmitters and their interactions with other molecular targets, thereby contributing to the overall pathology of cerebral malaria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Experimental Neuropharmacology, Biological Science Institute, Federal University of Pará, Belém, Brazil.
- Laboratory of Protozoology, Tropical Medicine Nucleus, Federal University of Pará, Belém, Brazil.
Förderung
- Universidade Federal do Pará
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
de Lima, R. M. S., Leão, L. K. R., Martins, L. C., Passos, A. D. C. F., Batista, E. J. O., Herculano, A. M., & Oliveira, K. R. H. M. (2025). Unveiling new perspectives about the onset of neurological and cognitive deficits in cerebral malaria: exploring cellular and neurochemical mechanisms. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1506282
Vancouver
de Lima RMS, Leão LKR, Martins LC, Passos ADCF, Batista EJO, Herculano AM, et al. Unveiling new perspectives about the onset of neurological and cognitive deficits in cerebral malaria: exploring cellular and neurochemical mechanisms. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1506282
BibTeX
@article{deLima2025,
author = {de Lima, Renato M S and Leão, Luana K R and Martins, Luana C and Passos, Adelaide da C Fonseca and Batista, Evander de J Oliveira and Herculano, Anderson M and Oliveira, Karen R H M},
title = {Unveiling new perspectives about the onset of neurological and cognitive deficits in cerebral malaria: exploring cellular and neurochemical mechanisms},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
volume = {15},
doi = {10.3389/fcimb.2025.1506282}
}
EUVIMED